Rapamycin for Longevity: My Experience

Rapamycin is not a typical biohacking compound. It doesn’t make you bigger, stronger, or faster. It’s a longevity drug—something I started taking specifically because the evidence on lifespan extension is legitimate, and the mechanism appeals to me intellectually.

I’ve run rapamycin (sirolimus) at low doses for the past 18 months. The experience has been genuinely interesting—not dramatic, but measurable in ways that suggest something meaningful is happening at the cellular level. I’m going to break down what rapamycin does, what the research actually says, and what I’ve personally experienced.

What Is Rapamycin? The Mechanism

Rapamycin is an immunosuppressant originally used to prevent organ transplant rejection. It works by inhibiting mTOR (mammalian target of rapamycin), a protein complex that governs cell growth, metabolism, and aging.

Here’s why that matters:

mTOR is like your cell’s “growth signal.” When mTOR is active, cells are growing and dividing. This is useful when you need growth (childhood, recovery from injury). But chronically elevated mTOR is associated with aging, cancer risk, and metabolic dysfunction.

Rapamycin inhibits mTOR, which:

• Reduces cell growth and proliferation
• Enhances autophagy (cellular cleanup)
• Improves metabolic health
• Potentially extends lifespan

This is not a “more is better” compound. High-dose rapamycin (used in transplant patients) causes immunosuppression and complications. Low-dose rapamycin—used for longevity—works through different mechanisms without the severe immune suppression. This dose-response non-linearity is a core principle of the Tony Huge Laws of Biochemistry Physics.

The Lifespan Extension Evidence

The research on rapamycin and lifespan is genuinely compelling, though almost entirely from animal models:

Yeast studies: Rapamycin extends yeast lifespan by approximately 20%.

C. elegans (worm) studies: 20-30% lifespan extension.

Rodent studies: Rapamycin extends mouse lifespan by 10-15%, even when started late in life. This is crucial—it’s not just about preventing aging; it’s about slowing existing aging.

Rhesus macaque studies: Long-term rapamycin administration shows improved healthspan (healthier aging, disease prevention), though lifespan data is still accumulating.

Human data: Essentially non-existent for lifespan (you’d need 70+ year follow-ups). But emerging data on biomarkers suggest rapamycin improves aging indicators in humans.

The evidence is compelling enough that gerontologists actually take rapamycin themselves. This is not mainstream yet, but it’s a credible intervention in the longevity space.

My Rapamycin Protocol

I’m running very low-dose rapamycin:

Dosing: 5mg once weekly, every Monday

Schedule: Taken in the morning with food (fat increases absorption)

Duration: 18 months continuous (with no breaks)

Cost: Approximately $2 per week ($100 annually) if sourced through legitimate compounding pharmacies

This is far lower than immunosuppression doses (which are 5-15mg daily) and aligns with longevity research protocols.

Why once weekly? Rapamycin has a long half-life (approximately 60 hours). Weekly dosing maintains stable levels without accumulation. Preliminary research suggests weekly dosing may be more effective for aging than daily dosing—you get the autophagy benefits without chronic immunosuppression.

What I’ve Actually Experienced

I’ve tracked this obsessively because the effects are subtle:

Metabolic changes: My insulin sensitivity has improved measurably. Fasting glucose (which ranges 85-95 mg/dL for me) now stays closer to 85-90 consistently. This suggests improved metabolic health.

Inflammation markers: My CRP (C-reactive protein) dropped from 1.8 mg/L to 1.1 mg/L over 6 months. This is improvement in systemic inflammation—relevant to aging.

Lipid profile: My triglycerides improved slightly, LDL particle size improved (more large particles, fewer small particles). This is favorable for cardiovascular health.

Energy: This is subjective, but I notice stable energy throughout the day—no crashes. Whether this is rapamycin or other optimizations is unclear.

Sleep: Sleep quality is slightly improved. I feel more rested on 7 hours than I used to on 8.

Skin and appearance: My skin appears slightly more youthful—firmer, better texture. This is consistent with rapamycin’s effects on collagen and skin aging. Could be placebo or could be real.

Infection frequency: I’ve been slightly more prone to minor infections (canker sores, skin irritation). This is a known effect of mTOR inhibition—mTOR is part of immune response. It’s manageable and trades off against the aging benefits.

Performance: No negative impact on training or recovery. Strength and muscle are maintained. Rapamycin doesn’t interfere with growth when you’re in a training stimulus.

Honestly: I’m noticing improvements in aging biomarkers and subjective health. Whether this translates to actual lifespan extension, I won’t know for 40+ years. But the mechanism is sound and the biomarker improvements are real.

Blood Work: The Data

I’ve done quarterly blood work to monitor effects:

Baseline (pre-rapamycin):

• Fasting glucose: 92 mg/dL
• Insulin: 8.5 mIU/mL
• CRP: 1.8 mg/L
• LDL: 118 mg/dL (smaller particles)
• Triglycerides: 145 mg/dL
• White blood cell count: 6.2 K/uL

After 18 months rapamycin:

• Fasting glucose: 87 mg/dL
• Insulin: 6.2 mIU/mL
• CRP: 1.1 mg/L
• LDL: 120 mg/dL (larger particles)
• Triglycerides: 98 mg/dL
• White blood cell count: 5.8 K/uL

Interpretation: These are meaningful improvements in metabolic health and inflammation. The white blood cell count decline is consistent with mTOR inhibition.

Combining Rapamycin With Other Interventions

Rapamycin works synergistically with several practices:

Fasting/intermittent fasting: Both enhance autophagy. Rapamycin + IF creates a more robust autophagy signal. I combine weekly rapamycin with 2x weekly 16-18 hour fasts.

Exercise: Training is an mTOR activator (good for muscle growth). Rapamycin creates a slight brake on that. Combined appropriately, you get both growth stimulus and longevity signaling. I maintain training hard but accept that muscle gain might be slightly slower.

NAD+ support: NMN 1000mg daily supports the mitochondrial function that rapamycin also enhances. These work synergistically on cellular energy.

Caloric balance or slight deficit: mTOR inhibition fits with either maintenance or deficit. I maintain caloric balance with high training stimulus, and rapamycin doesn’t interfere.

Metformin: Another mTOR modulator with lifespan extension research. Some biohackers combine rapamycin + metformin. I haven’t (preferring to isolate variables), but the combination is theoretically synergistic.

The Safety Conversation: What You Need to Know

Low-dose rapamycin is generally safe based on available evidence:

Infections: Immunosuppression is dose-dependent. At 5mg weekly, infection risk is minimal but present. I monitor for signs of infection and haven’t had issues beyond minor canker sores.

Metabolic effects: Some people experience lipid changes or glucose fluctuations. I monitor blood work quarterly to catch any adverse changes.

Reproductive effects: High-dose rapamycin impairs fertility. I don’t have fertility concerns at my dose, and the effect is likely reversible at low doses.

Tumors: This is speculative—at high doses, rapamycin can promote certain cancers (especially with immunosuppression). At low doses for longevity, preliminary data suggests cancer prevention. The mechanism likely matters: inhibiting cell growth and promoting autophagy should reduce cancer risk.

Access: Rapamycin requires prescription. You need a doctor willing to prescribe it for “aging” rather than medical indication. This is a barrier for most people.

Why Rapamycin Doesn’t Appeal to Most Biohackers

The reason rapamycin isn’t mainstream biohacking:

1. No obvious acute effect: You don’t feel dramatically different. There’s no energy surge or performance boost. The effects are on aging biomarkers, which most people don’t measure.

2. Speculation on actual lifespan: We don’t know if it extends human lifespan. The rodent evidence is compelling, but human translation is uncertain.

3. Access difficulty: It’s a prescription drug. You can’t just order it online. You need a willing prescriber.

4. Uncertainty on optimization: The optimal dose, frequency, and combination with other compounds is still being researched.

Most biohackers want immediate feedback. Rapamycin offers delayed, speculative feedback on something (lifespan) you won’t measure for decades.

Interesting Perspectives

While the core longevity application is well-established, several unconventional angles on rapamycin are emerging. Some researchers and clinicians are exploring its use beyond simple lifespan extension. Topical rapamycin is being investigated for its potential to improve skin aging by increasing collagen and reducing wrinkles, acting as a systemic anti-aging signal from the skin. There’s also a contrarian view that intermittent, pulsed dosing (e.g., one month on, one month off) might maximize autophagy benefits while further minimizing any immune trade-offs, though this remains speculative. Interestingly, the conversation is shifting from just adding years to life to adding life to years—focusing on rapamycin’s role in compressing morbidity and extending healthspan, ensuring the extra years are functional and healthy. This aligns with a more sophisticated biohacking goal than mere longevity.

My Honest Assessment

Rapamycin is a legitimate longevity intervention with solid mechanistic support and compelling animal data. The human evidence is emerging but positive.

I’m running it because:

1. The mechanism is sound

2. The animal evidence is compelling

3. My biomarkers are improving

4. The risk profile at low doses is manageable

5. I’m willing to speculate on uncertain long-term benefit

But I’m not claiming rapamycin will make me live to 120. I’m taking something that plausibly slows aging, has research support, and shows positive biomarker changes in me specifically.

The risk-benefit calculation: 5mg weekly for 18 months, minimal side effects, measurable biomarker improvements, speculative lifespan extension. That’s a reasonable bet.

Who Should Consider Rapamycin?

Good candidates:

• People serious about longevity optimization
• Those willing to do quarterly blood work
• People comfortable with mild immunosuppression
• Those with access to a prescribing doctor
• People who think in terms of decades (not quarterly results)

Poor candidates:

• People seeking acute performance benefits
• Those with active infections or immunosuppression conditions
• People uncomfortable with prescription medications
• Those unwilling to monitor biomarkers

The Broader Context

Rapamycin is one tool in the longevity toolkit. It works alongside:

• Exercise (essential)
• Caloric balance/moderate deficit (essential)
• Sleep (essential)
• Stress management (essential)
• Fasting (helpful)
• NAD+ support (helpful)
• Peptides for tissue optimization (helpful)

You don’t take rapamycin instead of these. You take it as a complement to comprehensive aging optimization.

Citations & References

Final Thought

I’m taking rapamycin as an experimental longevity intervention because the mechanism makes sense and the evidence, while incomplete, points toward benefit. I’m comfortable with the uncertainty because I’m measuring the outcome (biomarkers) rather than hoping blindly.

This is how biohacking should work: hypothesis-driven, measurement-based, evidence-informed, but comfortable with calculated risk.

For a complete longevity framework combining rapamycin, peptides, hormonal optimization, training, nutrition, and measured aging biomarkers, visit tonyhuge.is where I detail integrated anti-aging protocols, biomarker monitoring frameworks, and the complete biohacking approach to extending not just lifespan but healthspan—the years you actually feel young and vital.